Chie Hatori

Discovery of the First Non-Peptide Full Agonists for the Human Bradykinin B₂Receptor Incorporating 4-(2-Picolyloxy)quinoline and 1-(2-Picolyl)benzimidazole Frameworks

Yuki Sawada, Hiroshi Kayakiri, Yoshito Abe et al. · Journal of Medicinal Chemistry · 2004 · 113 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

The identification of an orally active, nonpeptide bradykinin B₂ receptor antagonist, FR173657

Masayuki Asano, Noriaki Inamura, Chie Hatori et al. · British Journal of Pharmacology · 1997 · 108 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +10

A Novel Class of Orally Active Non-Peptide Bradykinin B₂ Receptor Antagonists. 1. Construction of the Basic Framework

Yoshito Abe, Hiroshi Kayakiri, Shigeki Satoh et al. · Journal of Medicinal Chemistry · 1998 · 91 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

A Novel Class of Orally Active Non-Peptide Bradykinin B₂ Receptor Antagonists. 3. Discovering Bioisosteres of the Imidazo[1,2-<i>a</i>]pyridine Moiety

Yoshito Abe, Hiroshi Kayakiri, Shigeki Satoh et al. · Journal of Medicinal Chemistry · 1998 · 79 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

A Novel Class of Orally Active Non-Peptide Bradykinin B₂ Receptor Antagonists. 4. Discovery of Novel Frameworks Mimicking the Active Conformation

Yoshito Abe, Hiroshi Kayakiri, Shigeki Satoh et al. · Journal of Medicinal Chemistry · 1998 · 62 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17